Skip to main content
. 2021 Oct 19;11:753920. doi: 10.3389/fonc.2021.753920

Table 2.

Results of genome-wide association study (GWAS) for logp2PSA in the cohort.

SNP CHR Position a Loci Gene Stage A/a b RAF c Counts (aa/Aa/AA) d Mean levels (pg/ml) (aa/Aa/AA) d Beta (SE) p-value e
rs72725879 8 128103969 8q24.21 PRNCR1 1 T/C 0.76 51/321/495 17.02/29.11/41.78 0.18 (0.037) 2.08 × 10−6
2 T/C 0.76 70/393/636 22.23/27.10/38.90 0.12 (0.030) 6.24 × 10−5
Combined T/C 0.76 121/714/1131 19.86/27.99/40.18 0.14 (0.023) 2.28 × 10−9
rs13254738 8 128104343 8q24.21 PRNCR1 1 C/A 0.75 50/341/485 15.74/29.38/43.05 0.19 (0.037) 4.22 × 10−7
2 C/A 0.76 73/403/648 27.16/25.94/38.82 0.10 (0.029) 3.90 × 10−4
Combined C/A 0.76 123/744/1133 21.78/27.48/40.64 0.13 (0.023) 5.31 × 10−9
a

Chromosome position based on human genome build 37.

b

A/a, Risk allele/reference allele.

c

RAF indicates the frequency for risk allele A.

d

aa, indicating homozygous with two reference alleles; Aa, heterozygous; AA, indicating homozygous with two risk alleles.

e

P-value was based on multivariate linear regression analysis, adjusted for age and eigen.